CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Torrent Pharmaceuticals Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Torrent Pharmaceuticals Ltd
Torrent House, Off. Ashram Road
Phone: +91 7926599000p:+91 7926599000 AHMEDABAD, 380009  India Ticker: TORNTPHARMTORNTPHARM
Business Summary
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board SamirMehta 61 7/30/2014 4/1/2001
Chairman Emeritus SudhirMehta 70 3/31/2024 2/1/2003
Chief Financial Officer, Executive Director - Finance SudhirMenon 9/1/2018 9/1/2018
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Zyg Pharma Pvt Ltd. 172 Zakaria Bunder Road Mumbai Maharashtra India
Bio-Pharm, Inc. 2091 Hartel Avenue Levittown PA United States

Business Names
Business Name
500420
Bio-Pharm, Inc.
Curatio Healthcare (I) Pvt Ltd
8 additional Business Names available in full report.

General Information
Number of Employees: 14,916 (As of 3/31/2024)
Outstanding Shares: 338,445,440 (As of 9/30/2024)
Shareholders: 74,023
Stock Exchange: NSE
Fax Number: +91 7926582100


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024